Revenue QQ4 2025: 212,489,760 CNY; YoY growth (four-quarter period): +10.9%; QoQ change: β25.8%.
Gross Profit QQ4 2025: 132,301,290 CNY; Gross Margin: 62.26%; YoY: β2.31%; QoQ: β31.00%.
Operating Income QQ4 2025: 2,277,360 CNY; Operating Margin: 1.07%; YoY: β90.16%; QoQ: β94.60%.
EBITDA QQ4 2025: 5,325,640 CNY; EBITDA Margin (EBITDARatio): 2.51%.
Net Income QQ4 2025: β4,414,106 CNY; Net Margin: β2.08%; YoY: β115.64%; QoQ: β103.29%.
EPS (basic/diluted) QQ4 2025: β0.0048 / β0.0052 CNY; Weighted Avg Shares (diluted): 847,309,000.
Cash Flow QQ4 2025: Operating cash flow β16,674,349 CNY; Free cash flow β16,723,792 CNY.
Balance Sheet (as of 2025-12-31): Total assets 2,030,498,324 CNY; Cash & equivalents + short-term investments 1,842,209,804 CNY; Total liabilities 566,146,107 CNY; Total stockholdersβ equity 1,464,352,216 CNY; Net debt = β1,288,115,852 CNY (net cash position).
Liquidity: Net cash position and large liquidity headroom suggest capacity to fund R&D and expansion while awaiting sustained profitability.